1: Sang X, Zhang Y, Fang F, Gao L, Tao Y, Li X, Zhang Z, Wang J, Tian Y, Li Z,
Yao D, Wu Y, Chu X, Zhang K, Ma L, Lu L, Chen Y, Yu J, Zhuo R, Wu S, Zhang Z,
Pan J, Hu S. BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting
Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia. J Immunol Res. 2022
Aug 1;2022:7912484. doi: 10.1155/2022/7912484. PMID: 35958877; PMCID:
PMC9359861.
2: Sternicki LM, Nonomiya J, Liu M, Mulvihill MM, Quinn RJ. Native Mass
Spectrometry for the Study of PROTAC GNE-987-Containing Ternary Complexes.
ChemMedChem. 2021 Jul 20;16(14):2206-2210. doi: 10.1002/cmdc.202100113. Epub
2021 May 4. PMID: 33792163; PMCID: PMC8359942.
3: Pillow TH, Adhikari P, Blake RA, Chen J, Del Rosario G, Deshmukh G, Figueroa
I, Gascoigne KE, Kamath AV, Kaufman S, Kleinheinz T, Kozak KR, Latifi B, Leipold
DD, Sing Li C, Li R, Mulvihill MM, O'Donohue A, Rowntree RK, Sadowsky JD, Wai J,
Wang X, Wu C, Xu Z, Yao H, Yu SF, Zhang D, Zang R, Zhang H, Zhou H, Zhu X,
Dragovich PS. Antibody Conjugation of a Chimeric BET Degrader Enables in vivo
Activity. ChemMedChem. 2020 Jan 7;15(1):17-25. doi: 10.1002/cmdc.201900497. Epub
2019 Nov 14. PMID: 31674143.
4: Fang F, Lu J, Sang X, Tao YF, Wang JW, Zhang ZM, Zhang YP, Li XL, Xie Y, Wu
SY, Chu XR, Li G, Wu D, Chen YL, Yu JJ, Jia SQ, Feng CX, Tian YY, Li ZH, Ling J,
Hu SY, Pan J. Super-enhancer profiling identifies novel critical and targetable
cancer survival gene LYL1 in pediatric acute myeloid leukemia. J Exp Clin Cancer
Res. 2022 Jul 16;41(1):225. doi: 10.1186/s13046-022-02428-9. PMID: 35842703;
PMCID: PMC9288051.